Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus

Mucosal Immunology

Volumn 4, Issue 3, 2011, Pages 335-342

  Wira, C R ^a   Ghosh, M ^a   Smith, J M ^a,b   Shen, L ^a   Connor, R I ^a   Sundstrom, P ^a   Frechette, G M ^c   Hill, E T ^a   Fahey, J V ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Janet Weis Children s Hospital   (United States)

^c BOWDOIN COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CELL FUNCTION; CELL SECRETION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VAGINA SECRETION;

EID: 79955093737     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.72     Document Type: Article

References (56)

1. Wira, C.R., Fahey, J.V., Sentman, C.L., Pioli, P.A. & Shen, L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206, 306-335 (2005). (Pubitemid 41105178)
2. Kutteh, W.H., Mestecky J. & Wira, C.R. Mucosal immunity in the human female reproductive tract. In Mucosal Immunology (Mestecky, J. et al., eds) 1631-1647 (Academic Press, New York, 2005).
3. WHO. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates, Geneva, Switzerland, (2005).
4. Fidel, P.L. Jr History and update on host defense against vaginal candidiasis. Am. J. Reprod. Immunol. 57, 2-12 (2007). (Pubitemid 44911601)
5. Marot-Leblond, A. et al. Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test. J. Clin. Microbiol. 47, 3821-3825(2009).
6. Wira, C.R. & Fahey, J.V. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. Aids 22, 1909-1917 (2008).
7. Wira, C.R. & Fahey, J.V. The innate immune system: gatekeeperto the female reproductive tract. Immunology 111, 13-15 (2004). (Pubitemid 38091044)
8. Wira, C.R., Grant-Tschudy, K.S. & Crane-Godreau, M.A. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am. J. Reprod. Immunol. 53, 65-76 (2005). (Pubitemid 40347596)
9. Pioli, P.A. et al. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect. Immun. 72, 5799-5806 (2004). (Pubitemid 39303691)
10. Schaefer, T.M., Desouza, K., Fahey J.V., Beagley K.W. & Wira, C.R. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 112, 428-436 (2004). (Pubitemid 38859521)
11. Schaefer, T.M., Fahey, J.V., Wright, J.A. & Wira, C.R. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J. Immunol. 174, 992-1002 (2005). (Pubitemid 40094295)
12. Fahey, J.V., Schaefer, T.M., Channon, J.Y. & Wira, C.R. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum. Reprod. 20, 1439-1446 (2005). (Pubitemid 40852232)
13. Meter, R.A., Wira, C.R. & Fahey, J.V. Secretion of monocyte chemotactic protein-1 by human uterine epithelium directs monocyte migration in culture. Fertil. Steril. 84, 191-201 (2005). (Pubitemid 40991481)
14. Schaefer, T.M., Fahey, J.V., Wright, J.A. & Wira, C.R. Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am. J. Reprod. Immunol. 54, 193-202(2005). (Pubitemid 41309277)
15. Fahey, J.V., Wallace, P.K., Johnson, K., Guyre, P.M. & Wira, C.R. Antigen presentation by human uterine epithelial cells to autologous T cells. Am. J. Reprod. Immunol. 55, 1-11 (2006). (Pubitemid 43328930)
16. Wallace, P.K. et al. MHC class II expression and antigen presentation by human endometrial cells. J. Steroid. Biochem. Mol. Biol. 76, 203-211 (2001). (Pubitemid 32510683)
17. Fahey, J.V., Humphrey, S.L, Stern, J.E. & Wira, C.R. Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol. Invest. 27, 167-180 (1998). (Pubitemid 28298287)
18. Wira, C., Fahey, J., Wallace, P. & Yeaman, G. Effect of the menstrual cycle on immunological parameters in the human female reproductive tract. J. Acquir. Immune. Defic. Syndr. 38 (Suppl 1), S34-S36 (2005). (Pubitemid 40627709)
19. Fahey, J.V. & Wira, C.R. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J. Infect. Dis. 185, 1606-1613 (2002). (Pubitemid 34587522)
20. King, A.E., Critchley H.O. & Kelly, R.W. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod. 6, 191-196 (2000). (Pubitemid 30094283)
21. King, A.E., Fleming, D.C., Critchley, H.O. & Kelly, R.W. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol. Hum. Reprod. 8, 341-349(2002). (Pubitemid 34303242)
22. King, A.E., Fleming, D.C., Critchley, H.O. & Kelly, R.W. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J. Reprod. Immunol. 59, 1-16 (2003). (Pubitemid 36918496)
23. Ganz, T & Lehrer, R.I. Defensins. Pharmacol. Ther. 66, 191-205 (1995).
24. Duits, LA. et al. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol. Med. Microbiol. 38, 59-64 (2003). (Pubitemid 37297444)
25. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720 (2003). (Pubitemid 41070812)
26. Hocini, H. et al. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin. Diagn. Lab Immunol. 7, 515-518 (2000). (Pubitemid 30263051)
27. Porter, E. et al. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect. Immun. 73, 4823-4833 (2005). (Pubitemid 41105639)
28. Quinones-Mateu, M.E. et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 17, F39-48 (2003). (Pubitemid 38147012)
29. Tomee, J.F, Hiemstra, P.S., Heinzel-Wieland, R. & Kauffman, H.F. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176, 740-747 (1997). (Pubitemid 27360541)
30. Wahl, S. et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis. 3 (Suppl 1), S64-S69 (1997). (Pubitemid 27242064)
31. Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996). (Pubitemid 26299570)
32. Cocchi, F. et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815(1995).
33. Valore, E.V et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633-1642 (1998). (Pubitemid 28198492)
34. Ghosh, M. et al. CCL20/MIP3alphaisanovelanti-HIV-1 molecule of the human female reproductive tract. Am. J. Reprod. Immunol. 62, 60-71 (2009).
35. Ghosh, M. et al. Trappin-2/Elafin: a novel innate anti-HIV-1 molecule of the human female reproductive tract. Immunology 129, 207-219 (2009).
36. Martin, R. et al. Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int. Microbiol. 11, 261-266 (2008).
37. Fahey, J.V., Kaushic, C. & Wira, C.R. Human uterine epithelial cells: influence of culture conditions and stromal cells on epithelial cell transepithelial cell resistance. In Reproducth/e Immunology (Gupta, S.K., ed) 366-378 (Narosa Publishing House, New Delhi, 1999).
38. Bingle, C.D. & Vyakarnam, A. Novel innate immune functions of the whey acidic protein family. Trends Immunol. 29, 444-453 (2008).
39. Garzino-Demo, A. Chemokines and defensins as HIV suppressive factors: an evolving story. Curr. Pharm. Des. 13, 163-172 (2007). (Pubitemid 46085290)
40. Schols, D. HIV co-receptors as targets for antiviral therapy. Curr. Top. Med. Chem. 4, 883-893 (2004). (Pubitemid 38854847)
41. Calderone, R. Taxonomy and biology of Candida. In Candida and Candidiasis (Calderone, R., ed) 307-325 (ASM Press, Washington, DC, 2002).
42. Shen, L. et al. Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. Cell Immunol. 230, 23-32 (2004). (Pubitemid 39482359)
43. Thomachot, M.C. et al. Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes. Int. J. Cancer 110, 710-720 (2004). (Pubitemid 38746030)
44. Perez, O.D., Mitchell, D. & Nolan, G.P. Differential role of ICAM ligands in determination of human memory T cell differentiation. BMC Immunol. 8, 2 (2007).
45. Crane-Godreau, M.A. & Wira, C.R. Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infect. Immun. 73, 4231-4237 (2005). (Pubitemid 40923166)
46. Schlee, M. et al. Probiotic lactobacilli and VSL. Clin. Exp. Immunol. 151, 528-535 (2008).
47. Zervomanolakis, I. et al. Physiology of upward transport in the human female genital tract. Ann. NY Acad. Sci. 1101, 1-20 (2007). (Pubitemid 47092719)
48. Chattopadhyay A. et al. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1 -infected persons. Infect. Immun. 72, 1956-1963 (2004). (Pubitemid 38419906)
49. Py B. et al. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS One 4, e5006 (2009).
50. Shugars, D. Endogenous mucosal antiviral factors of the oral cavity. J. Infect. Dis. 179 (Suppl 3), S431-S435 (1999). (Pubitemid 29198392)
51. Hiemstra, P.S. et al. Antibacterial activity of antileukoprotease. Infect. Immun. 64, 4520-4524 (1996). (Pubitemid 26357053)
52. Hieshima, K. et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170, 1452-1461 (2003). (Pubitemid 36139514)
53. Aasa-Chapman, M.M., Seymour, C.R., Williams, I. & McKnight, A. Novel envelope determinants for CCR3 use by human immunodeficiency virus. J. Virol. 80, 10884-10889 (2006). (Pubitemid 44628937)
54. Margolis, L. & Shattock, R. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat. Rev. Microbiol. 4, 312-317 (2006).
55. Ghosh, M. et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels with IgA and IgG antibodies. PLoS One 5, e11366 (2010).
56. Steele, C. & Fidel, P.L. Jr Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect. Immun. 70, 577-583 (2002). (Pubitemid 34083815)